Search
for
Sort by
Research 511–540 of 1000+
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Immunoregulatory Effects of Myeloid-Derived Suppressor Cell Exosomes in Mouse Model of Autoimmune Alopecia Areata
- Trichoscopy pattern and evaluation of serum vitamin D status in alopecia areata
- A Comparative Clinical and Trichoscopic Study Between Fractional Radiofrequency Microneedling Versus Intralesional Steroids in Treatment of Alopecia Areata
- Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Health‐related quality of life of adult and adolescent patients living with alopecia areata in Australia
- Anxiety, depression, and quality of life in children and adults with alopecia areata: A systematic review and meta-analysis
- Health‐related quality of life and well‐being in pediatric patients with alopecia areata and their caregivers
- Candida antigen immunotherapy versus steroid in the treatment of alopecia areata
- Alopecia areata - need for a revision in morphological classification and scoring
- Prognosis in patients with alopecia areata with poliosis: A retrospective cohort study of 479 cases
- Classification Framework for Healthy Hairs and Alopecia Areata: A Machine Learning (ML) Approach
- Altered hypothalamus functional connectivity and psychological stress in patients with alopecia areata
- Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata
- The Burden of Disease in Alopecia Areata: Canadian Online Survey of Patients and Caregivers
- THE EFFECT OF AUTOLOGOUS PLATELET RICH PLASMA (PRP) ON PATIENTS WITH ALOPECIA AREATA
- Alopecia Areata: An Updated Review for 2023
- Quality of life in children and adolescents with alopecia areata—A systematic review
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
- Altered expression of intracellular Toll-like receptors in peripheral blood mononuclear cells from patients with alopecia areata
- Serum-Based Assessment of Alopecia Areata Response to Treatment Using ATR-FTIR Spectroscopy
- Correlation between increased total serum IgE levels and clinical features in alopecia areata patients
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Single-cell analysis of temporal immune cell dynamics in alopecia areata reveals a causal role for clonally expanded CD8+ T cells in disease
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- A Novel Fusion Technique for Early Detection of Alopecia Areata Using ResNet-50 and CRSHOG
- Correlation of trichoscopic findings in androgenetic alopecia and the disease severity
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer